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Complex regional pain syndrome (CRPS) is a chronic neuropathic pain disorder characterized by neuropathic pain associated
with local edema and changes suggestive of autonomic involvement such as altered sweating, skin color, and skin temperature
of the aﬀected region. CRPS was described associated with several diseases, such as trauma, psychiatric conditions, and cancer.
However, no case associated with Still’s disease has been previously described. In this paper, the authors describe the ﬁrst case of
CRPS associated with Still’s disease.
1.Introduction
Complex regional pain syndrome (CRPS), also known as
reﬂex sympathetic dystrophy and causalgia, algodystrophy,
Sudeck’s atrophy, hand-shoulder syndrome, neuroalgodys-
trophy, and posttraumatic sympathetic dystrophy, is a
chronic neuropathic pain disorder characterized by auto-
nomic ﬁndings and typically develops in an extremity after
acute tissue trauma. In addition to classic neuropathic
pain characteristics (intense burning pain, hyperalgesia, and
allodynia), CRPS is associated with local edema and changes
suggestive of autonomic involvement (altered sweating, skin
color, and skin temperature in the aﬀected region). Trophic
changes to the skin, hair, and nails and altered motor
function (loss of strength, decreased active range of motion,
and tremors) may also occur. CRPS is subdivided to CRPS-
I (reﬂex sympathetic dystrophy) and CRPS-II (causalgia),
reﬂecting the absence or presence of documented nerve
injury, respectively [1].
Although CRPS was ﬁrst described in isolation, it can
be linked to several diseases, such as trauma [1], psychiatric
conditions [2], and cancer [3]. However, no case associated
with Still’s disease has been previously described.
Therefore, the objective of this study was to describe the
ﬁrst case of CRPS associated with Still’s disease.
2.CaseReport
A 50-year-old female began to complain in 2005 of pol-
yarthritis of her knees, wrists, elbows, ankles, and hand
metacarpophalangeal joints associated with fever, morning
stiﬀness (for 4 hours), and evanescent rash. Laboratory
results demonstrated leukocytosis, high levels of ferritin
401ng/mL (reference value: 22–322ng/mL), and erythrocyte
sedimentation rate of 57mm/1st hour. Antinuclear an-
tibodies and rheumatoid factor were absent. Serologies for
B and C hepatitis, HIV, HTLV 1 and 2, Epstein-Barr, ru-
bella, toxoplasmosis, mononucleosis, rubella, and syphilis
were negative. Echocardiography, liver and renal functions,
myelogram, and bone marrow biopsy were also normal. A
diagnosis of adult Still’s disease was performed, and the
patient was treated with nonsteroidal anti-inﬂammatory
drugs and glucocorticoids. She evolved with no fever and
improvement of polyarthritis; however, the knees, wrists,
and elbows continued to be inﬂamed. Methotrexate (until
20mg/week)wasaddedtothescheme.Shecontinuedtohave
arthritis, sporadic fever, morning stiﬀness (for 2 hours), and
leukocytosis (12,610). Treatment with inﬂiximab (300mg at
0, 2, and 6 weeks and then every 8 weeks, intravenously)
was then initiated. She experienced no improvement after
6 months. Inﬂiximab was then replaced by tocilizumab2 Autoimmune Diseases
(8mg/kg dose, monthly). She experienced marked improve-
ment after this drug treatment. This approach also allowed
reduction of the prednisone dose to 5mg/day. In 2007,
the patient received a diagnosis of carpal tunnel syndrome
conﬁrmed by electroneurography and was operated upon. In
2009, she noticed abrupt pain and edema in her right hand,
clinical examination of which demonstrated cold swelling of
the entire right hand and local diaphoresis. Thus, a diagnosis
of complex regional pain syndrome type-I arthropathy was
made. She was treated with prednisone 20mg/day, NSAID,
and physical therapy with improvement. She experienced
ﬁve recurrences of CRPS, with good response to the thera-
peutic scheme outlined above. Currently, the patient is as-
ymptomatic, with levels of ferritin at 21.5ng/mL, CRP at
<5mg/L, and ESR at 3mm/1st hour. The patient is also
currently treated with tocilizumab monthly, prednisone at
2.5mg/day, and methotrexate at 20mg/week.
3. Discussion
This is the ﬁrst description of the cooccurrence of CRPS in a
patient with Still’s disease.
Noxious events, including minor trauma, bone fracture,
or surgery of the aﬀected limb, often determine the onset of
CRPS I. Occasionally, the disease develops after other med-
ical events such as shoulder trauma, myocardial infarction,
or a lesion of the central nervous system. In the present
case, the patient had a previous carpal tunnel syndrome sur-
gery performed at her wrist. In fact, several studies have
demonstrated that the surgical stimulus may produce the
clinical picture of CRPS.
Regarding treatment, nonsteroidal anti-inﬂammatory
drugs have not been demonstrated to have signiﬁcant an-
algesic properties in CRPS. The use of opioids in CRPS
has not been studied. Tricyclic antidepressants are the most
well-studied medications in the context of neuropathic pain,
and they have shown an analgesic eﬀect. Glucocorticoids
taken orally have clearly demonstrated eﬃcacy in con-
trolled trials [4]. There is no evidence that other immune-
modulating therapies, notably intravenous immunoglobu-
lins or immunosuppressive drugs, are eﬀective in the treat-
ment of CRPS. Subcutaneous calcitonin only had a mild
eﬀect on spontaneous pain [5]. However, bisphosphonates
(alendronate, clodronate) induced signiﬁcant improvement
in pain, swelling, and movements [6].
Clinical experience and two prospective studies indicate
that physiotherapy is of the utmost importance in achieving
the recovery of function and rehabilitation [7, 8].
Inﬂammation may also play a role in this unique as-
sociation of Still’s disease and CRPS. In fact, an increased
inﬂammatory response is an important pathophysiological
mechanisminCRPS[9].Indeed,someoftheclinicalfeatures
ofCRPS,particularlyinitsearlyphase,couldbeexplainedby
an inﬂammatory process [10]. Consistent with this idea, cor-
ticosteroids are often successfully used to treat acute CRPS
[4]. There is increasing evidence that localized neurogenic
inﬂammation might be involved in the generation of acute
edema, vasodilatation, and increased sweating. Scintigraphic
investigations using radiolabelled immunoglobulins show
extensive plasma extravasation in patients with acute CRPS
I[ 11]. Analysis of joint ﬂuid and synovial biopsies in CRPS
patients has revealed an increase in protein concentration,
synovial hypervascularity, and neutrophil inﬁltration [12].
Furthermore, synovial eﬀusion is enhanced in aﬀected
joints, as determined using MRI [13]. In acute untreated
CRPS I patients, protein extravasation elicited by strong
transcutaneous electrical stimulation was only provoked
on the aﬀected extremity compared with the normal side,
indicating that substance P might be involved [14].
In summary, our case represents the ﬁrst adult patient
with Still’s disease who had associated CRPS that recurred
after hand surgery. Either this operation or the inﬂammation
itself may have triggered CRPS development in this patient.
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